BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28801584)

  • 21. Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population.
    El Otmani I; El Agy F; El Baradai S; Bouguenouch L; Lahmidani N; El Abkari M; Benajah DA; Toughrai I; El Bouhaddouti H; Mouaqit O; Ibn Majdoub Hassani K; Mazaz K; Benjelloun EB; Ousadden A; El Rhazi K; Bouhafa T; Benbrahim Z; Ouldim K; Ibrahimi SA; Ait Taleb K; Chbani L
    Dis Markers; 2020; 2020():8459303. PubMed ID: 31998419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of clinicopathological features and prognosis between left-sided colon cancer and right-sided colon cancer].
    Gao X; Yu G; Liu P; Hao L; Liu L; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):647-653. PubMed ID: 28643309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.
    Mima K; Nowak JA; Qian ZR; Cao Y; Song M; Masugi Y; Shi Y; da Silva A; Gu M; Li W; Hamada T; Zhang X; Wu K; Meyerhardt JA; Baba H; Giovannucci EL; Chan AT; Fuchs CS; Ogino S; Nishihara R
    Oncotarget; 2016 Aug; 7(34):55098-55109. PubMed ID: 27391152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Primary Tumor Location on Survival After Curative Resection in Patients with Colon Cancer: A Meta-Analysis of Propensity Score-Matching Studies.
    Ishizuka M; Shimizu T; Shibuya N; Takagi K; Hachiya H; Nishi Y; Suda K; Aoki T; Kubota K
    Oncologist; 2021 Mar; 26(3):196-207. PubMed ID: 33031622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles.
    Imperial R; Ahmed Z; Toor OM; Erdoğan C; Khaliq A; Case P; Case J; Kennedy K; Cummings LS; Melton N; Raza S; Diri B; Mohammad R; El-Rayes B; Pluard T; Hussain A; Subramanian J; Masood A
    Mol Cancer; 2018 Dec; 17(1):177. PubMed ID: 30577807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HER2 status in patients with residual rectal cancer after preoperative chemoradiotherapy: the relationship with molecular results and clinicopathologic features.
    Park JS; Yoon G; Kim HJ; Park SY; Choi GS; Kang MK; Kim JG; Jang JS; Seo AN
    Virchows Arch; 2018 Oct; 473(4):413-423. PubMed ID: 30056472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery.
    Peng J; Lin J; Qiu M; Zhao Y; Deng Y; Shao J; Ding P; Zhang H; Wan D; Lu Z; Pan Z
    Tumour Biol; 2017 Jul; 39(7):1010428317709638. PubMed ID: 28671043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation in BRAF and SMAD4 associated with resistance to neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
    Jiang D; Wang X; Wang Y; Philips D; Meng W; Xiong M; Zhao J; Sun L; He D; Li K
    Virchows Arch; 2019 Jul; 475(1):39-47. PubMed ID: 31056731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of clinicopathological features and prognosis of 1315 cases in colorectal cancer located at different anatomical subsites.
    Feng Z; Shi X; Zhang Q; Zhang X; Li X; Chen Z; Liu D; Sun B; Zuo Y; Ren S
    Pathol Res Pract; 2019 Oct; 215(10):152560. PubMed ID: 31375274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites.
    Tan C; Wang Q; Yao S
    Am J Clin Oncol; 2024 Jun; 47(6):253-258. PubMed ID: 38251762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas.
    Kalady MF; Sanchez JA; Manilich E; Hammel J; Casey G; Church JM
    Dis Colon Rectum; 2009 Jun; 52(6):1039-45. PubMed ID: 19581844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of KRAS mutation, microsatellite instability, and tumor laterality on the prognosis of nonmetastatic colon cancer.
    Tran CG; Goffredo P; Mott SL; Hart A; You YN; Vauthey JN; Weigel RJ; Hassan I
    Surgery; 2022 Mar; 171(3):657-665. PubMed ID: 34865865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer.
    Popovici V; Budinska E; Tejpar S; Weinrich S; Estrella H; Hodgson G; Van Cutsem E; Xie T; Bosman FT; Roth AD; Delorenzi M
    J Clin Oncol; 2012 Apr; 30(12):1288-95. PubMed ID: 22393095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival trends for left and right sided colon cancer using population-based SEER database: A forty-five-year analysis from 1975 to 2019.
    Ulanja MB; Asafo-Agyei KO; Neelam V; Beutler BD; Antwi-Amoabeng D; Governor SB; Rahman GA; Djankpa FT; Ulanja RN; Nteim GB; Mabrouk T; Amankwah M; Alese OB
    Cancer Med; 2024 Apr; 13(8):e7145. PubMed ID: 38651190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating
    Ntavatzikos A; Spathis A; Patapis P; Machairas N; Peros G; Konstantoudakis S; Leventakou D; Panayiotides IG; Karakitsos P; Koumarianou A
    World J Gastroenterol; 2017 Aug; 23(32):5913-5924. PubMed ID: 28932083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancer.
    Erben P; Ströbel P; Horisberger K; Popa J; Bohn B; Hanfstein B; Kähler G; Kienle P; Post S; Wenz F; Hochhaus A; Hofheinz RD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1032-8. PubMed ID: 20947270
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Sideris M; Moorhead J; Diaz-Cano S; Haji A; Papagrigoriadis S
    Anticancer Res; 2017 Mar; 37(3):1349-1357. PubMed ID: 28314302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Li M; Li JY; Zhao AL; Gu J
    Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers.
    Shen H; Huang J; Pei H; Zeng S; Tao Y; Shen L; Zeng L; Zhu H
    Cancer Sci; 2013 Jan; 104(1):135-41. PubMed ID: 23004678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locally advanced rectal cancers with simultaneous occurrence of KRAS mutation and high VEGF expression show invasive characteristics.
    Krajnović M; Marković B; Knežević-Ušaj S; Nikolić I; Stanojević M; Nikolić V; Šiljić M; Jovanović Ćupić S; Dimitrijević B
    Pathol Res Pract; 2016 Jul; 212(7):598-603. PubMed ID: 27184911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.